文献速递细菌感染、耐药与抗菌药物

社区氟喹诺酮类抗菌药物消耗与尿路耐药大肠埃希菌感染的关联

Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
PubMed 文献 · Lancet Infect Dis · 2019-03-04

该研究在以色列1733个社区开展基于人群的病例对照研究,分析社区氟喹诺酮消耗与个体尿路氟喹诺酮耐药大肠埃希菌定植或感染风险的关联。

要点

  • 社区氟喹诺酮消耗越高,个体尿路耐药大肠埃希菌风险独立增加。
  • 自身未用氟喹诺酮者中关联仍显著,提示社区层面传播或暴露。
  • 评估耐药风险时应考虑社区抗菌药物消耗水平。

核心结论

  • 特定地理区域抗菌药物使用增加与个体获得耐药菌风险升高相关,独立于个人用药史和其他已知耐药危险因素。

研究设计与样本

  • 基于人群的病例对照研究,采用分层多变量logistic回归分析,纳入以色列1733个社区≥22岁成人电子病历数据。

主要发现

  • 限制于自身未使用氟喹诺酮者,结果仍显著。

临床怎么用

  • 临床评估尿路感染耐药风险时,除个人抗菌药物史外,可参考所在社区氟喹诺酮消耗水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unknown whether increased use of antibiotics in a community increases the risk of acquiring antibiotic resistance by individuals living in that community, regardless of prior individual antibiotic consumption and other risk factors for antibiotic resistance. METHODS: We used a hierarchical multivariate logistic regression approach to evaluate the association between neighbourhood fluoroquinolone consumption and individual risk of colonisation or infection of the urinary tract with fluoroquinolone-resistant Escherichia coli. We did a population-based case-control study of adults (aged ≥22 years) living in 1733 predefined geographical statistical areas (neighbourhoods) in Israel. A multilevel study design was used to analyse data derived from electronic medical records of patients enrolled in the Clalit state-mandated health service. FINDINGS: 300 105 events with E coli growth and 1 899 168 cultures with no growth were identified from medical records and included in the analysis. 45 427 (16·8%) of 270 190 women and 8835 (29·5%) of 29 915 men had fluoroquinolone-resistant E coli events. We found an independent association between residence in a neighbourhood with higher antibiotic consumption and an increased risk of bacteriuria caused by fluoroquinolone-resistant E coli. Odds ratios (ORs) for the quintiles with higher neighbourhood consumption (compared with the lowest quintile) were 1·15 (95% CI 1·06-1·24), 1·31 (1·20-1·43), 1·41 (1·29-1·54), and 1·51 (1·38-1·65) for women, and 1·17 (1·02-1·35), 1·24 (1·06-1·45), 1·35 (1·15-1·59), and 1·50 (1·26-1·77) for men. Results remained significant when the analysis was restricted to patients who had not consumed fluoroquinolones themselves. INTERPRETATION: These data suggest that increased use of antibiotics in specific geographical areas is associated with an increased personal risk of acquiring antibiotic-resistant bacteria, independent of personal history of antibiotic consumption and other known risk factors for antimicrobial resistance. FUNDING: None.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Low M, Neuberger A, Hooton TM, et al. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study. Lancet Infect Dis. 2019. PMID: 30846277. doi:10.1016/S1473-3099(18)30676-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。